Company intelligence / Profile preview

Arinna Lifesciences

Ahmedabad, Gujarat, Indiaarinnalifesciences.com ↗
Ownership
Private
Development stage
Other
01

Overview

Arinna Lifesciences develops and markets specialty finished dosage pharmaceuticals in India, with clinical focus in CNS and CVS (noted commercial product: Vortiroc, vortioxetine, approved for depression treatment).

Therapeutic areas
NeurologyPsychiatryCardiovascular
Modalities
Small moleculeTablet (finished dosage)
Industry
Biotech
02

Drug pipeline

1 asset

Amvalor Chrono

Unknown

Beyond the preview

Go deeper on Arinna Lifesciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arinna Lifesciences.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call